Mariner
STLN

Mariner’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Mariner’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,884
Closed -$5.01K – 3389
2024
Q2 		$5.01K Sell
10,884
-7,418
-41% -$6.33K ﹤0.01% 3145
2024
Q1 		$28.9K Hold
18,302
– – ﹤0.01% 3072
2023
Q4 		$37.3K Hold
18,302
– – ﹤0.01% 2964
2023
Q3 		$25.6K Buy
18,302
+1,391
+8% +$1.44K ﹤0.01% 2829
2023
Q2 		$9.3K Buy
+16,911
New +$8.95K ﹤0.01% 2812

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TAS
TIFF Advisory Services Radnor, Pennsylvania $408M AUM 20.34% 1-Year Est. Return
CI
Cincinnati Insurance Fairfield, Ohio $6.94B AUM 20.24% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Mariner's STLN Position: Q3 2024 in Review

Mariner sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q3 2024, closing a stake of 10,884 shares — an estimated $5.01K sold.

Mariner first reported a position in STLN in Q2 2023 and held it in 5 quarters. The position peaked at $37.3K in Q4 2023. 34 funds tracked by Wall St. Rank hold STLN as of Q3 2024.

  • Mariner reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Mariner sold 10,884 Starling Oncology Institute, Inc. Common Stock shares in Q3 2024, an estimated $5.01K.
  • Mariner first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
  • Mariner's Starling Oncology Institute, Inc. Common Stock position peaked at $37.3K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q3 2024.

Based on Mariner's 13F filing for Q3 2024, filed 13 Nov 2024.